This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: DREIMT: a drug repositioning database and prioritization tool for immunomodulation

Title DREIMT: a drug repositioning database and prioritization tool for immunomodulation
Abstract

Motivation Drug immunomodulation modifies the response of the immune system and can be therapeutically exploited in pathologies such as cancer and autoimmune diseases. Results DREIMT is a new hypothesis-generation web tool which performs drug prioritization analysis for immunomodulation. DREIMT provides significant immunomodulatory drugs targeting up to 70 immune cells subtypes through a curated database that integrates 4,960 drug profiles and ~2,6K immune gene expression signatures. The tool also suggests potential immunomodulatory drugs targeting user-supplied gene expression signatures. Final output includes drug-signature association scores, FDRs and downloadable plots and results tables. Availability http://www.dreimt.org Contact falshahrour@cnio.es ; ggomez@cnio.es

Apa Reference Troulé, K., López-Fernández, H., García-Martín, S., Reboiro-Jato, M., Carretero-Puche, C., Martorell-Marugán, J., Martín-Serrano, G., Carmona-Sáez, P., González-Peña, D., Al-Shahrour, F. & Gómez-López, G. (2020). DREIMT: a drug repositioning database and prioritization tool for immunomodulation. 10.1101/2020.06.24.168468
Doi 10.1101/2020.06.24.168468
Publication Date 24 Jun 2020
Publication Type Preprint
Researcher Pedro Carmona-Saez
Ontology Transcriptomics, Biological Databases, Expression Profiling, Web-service, Drug Discovery and design
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home